Vinayak Sudhapalli

Led a two-person analytics team delivering RWE, quantitative market research and commercial analytics for life sciences clients. Standardized workplans, QC gates and executive readouts, cutting cycle time about 30%.

Built cohort-based re-engagement models in Python and SQL using Salesforce usage and Jira data, reducing churn 8% among low-engagement clients. Developed AI-assisted analytics combining MRF payment data, usage signals and voice-of-customer interviews, increasing provider-account lifetime value 25%.

Performed retrospective observational analyses of medical and pharmacy claims and reimbursement data to characterize treatment patterns, utilization, patient journeys, payer access barriers, PA/step edits and rejection reasons. Built cohort and provider-targeting models across oncology and biologics, identifying opportunities within $3M+ in payer drug spend and $1.5M in annual Imcivree marketing a

Served as RWE pharmacy-benefits and market-access SME, translating evidence questions into custom data, SaaS and analytics solutions that influenced $3M+ in direct sales. Analyzed approvals, rejection reasons, PA/step restrictions, utilization and payer drug spend to explain $13M in oncology performance and design an $18M ESRD/oncology growth opportunity.

Integrated IQVIA LAAD/Xponent, MMIT PAR and RWE into a Tableau dashboard tracking $72M in product sales and coverage, enabling repeatable evidence reviews for brand and access stakeholders. Developed value-based pricing analyses tied to a $2M revenue opportunity across oncology, immunology and chronic disease.

Benchmarked physician efficiency against national averages using inferential statistics in R and T-SQL; segmented by geography and provider unit and quantified $250K quarterly / $1M annual utilization impact. Automated updates to ICD-10, CPT-4 and HCPCS indices, strengthening data integrity and reducing manual effort for recurring analytics.

Analyzed $37B in Medicare Part D costs by LIS/MA-PDP payment and member/plan dimensions, delivering national-level evidence and executive reporting to CMS. Automated 2,100+ payer reports and visualizations for UHC, BCBS, Anthem and Aetna using IQVIA LAAD and MMIT data.

Designed healthcare surveys and PRO questions for Chemolieve and Prolon; synthesized unmet need, cost-of-treatment and customer-experience evidence to support analytic plans and pricing/value narratives.

Analyzed prescription utilization and patient outcomes across 50+ pharmacies and developed a cost-utility and quality-of-life value model for breast-reconstruction pathways.

Pursued a Master of Science in IT Management Services, focusing on the intersection of technology and business management.

Earned a Master of Science in Health Care Decision Analysis, specializing in evidence-based decision-making for healthcare.

Completed a Doctor of Pharmacy (PharmD) program, gaining comprehensive knowledge in pharmaceutical sciences and clinical practice.